Skip to content Skip to footer
Tisotumab Vedotin-Tftv: Benefits, Reviews, Info, Side Effects!
Rx Details
Tisotumab Vedotin-Tftv
Tisotumab Vedotin-Tftv
Tisotumab vedotin
Prescription
Drug
Drugs
Breakthrough Therapy
Tisotumab Vedotin-Tftv is a medication used primarily for the treatment of certain types of cancer. Here are some potential benefits: – Targets cancer cells specifically – Reduces tumor size – Slows cancer progression – Provides an option for patients with advanced or recurrent cancer – May improve survival rates – Offers a treatment alternative when other therapies have failed
Abdominal Pain, Anemia, Constipation, Decreased Appetite, Diarrhea, Dry Eyes, Fatigue, Hair Loss, Increased Liver Enzymes, Nausea, Neutropenia, Nosebleeds, Peripheral Neuropathy, Rash, Thrombocytopenia
Tisotumab vedotin-tftv, marketed under the brand name Tivdak, is a medication used for the treatment of certain types of cancer, specifically cervical cancer. The typical dosage for Tivdak is based on the patient’s body weight. The recommended dose is 2 mg/kg, up to a maximum of 200 mg per infusion, administered intravenously over 30 minutes every 3 weeks until disease progression or unacceptable toxicity occurs. However, it’s important to note that the exact dosage and treatment regimen should be determined by a healthcare professional based on individual patient needs and medical condition. Always consult with a healthcare provider for personalized medical advice.
Cervical cancer
Safety profile of Tisotumab Vedotin-Tftv is favorable.
No Interactions Reported
$1,000 – $10,000
$15,000 for a 2.4 mg vial.

A Synopsis of

Tisotumab Vedotin-Tftv

Tisotumab Vedotin-Tftv is a novel drug that has shown promising results in the treatment of certain types of cancer. This medication works by targeting specific proteins on cancer cells, delivering a potent dose of chemotherapy directly to the tumor while minimizing damage to healthy cells.

Clinical trials have demonstrated the efficacy of Tisotumab Vedotin-Tftv in patients with advanced cervical cancer who have not responded to traditional treatments. In these studies, patients experienced significant tumor shrinkage and prolonged survival rates compared to standard chemotherapy regimens.

As with any medication, there are potential side effects to be aware of when taking Tisotumab Vedotin-Tftv. Common side effects may include fatigue, nausea, and hair loss. It is important to discuss any concerns or symptoms with your healthcare provider to ensure proper management and support throughout your treatment.

It is crucial to follow your healthcare provider’s instructions carefully when taking Tisotumab Vedotin-Tftv. This medication is typically administered intravenously in a clinical setting, and regular monitoring may be necessary to assess your response to treatment and manage any side effects.

If you have been diagnosed with advanced cervical cancer or another type of cancer that may benefit from Tisotumab Vedotin-Tftv, talk to your healthcare provider about whether this medication is a suitable option for you. They can provide personalized guidance based on your individual medical history and treatment goals.

Overall, Tisotumab Vedotin-Tftv represents a promising advancement in the field of oncology and offers new hope for patients with difficult-to-treat cancers. By working closely with your healthcare team and staying informed about your treatment plan, you can optimize the benefits of this medication and improve your chances of a successful outcome.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN